
Ammika 500mg Injection
Marketer
Loco Healthcare Pvt Ltd
Salt Composition
Amikacin (500mg)
Overview Ammika 500mg Injection
Cefamika 500mg Injection combats bacterial infections affecting diverse body areas, including the urinary tract, bones, joints, lungs (such as pneumonia), brain, and bloodstream. Prophylactically, it's administered to hospitalized individuals to ward off infections. This antibiotic halts bacterial proliferation. Administered intravenously (drip) or intramuscularly by a healthcare professional, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; incomplete courses risk infection recurrence or exacerbation. Minor side effects like injection site irritation and elevated blood urea nitrogen may occur. Persistent symptoms or treatment ineffectiveness warrant immediate medical consultation. High doses may exceptionally induce vertigo, nephrotoxicity, and hearing impairment, necessitating regular kidney function, hearing, and urine analysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Primary Ingredients of Ammika 500mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ammika 500mg Injection
Infections caused by bacteria
Major Benefits of Ammika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ammika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Ammika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ammika 500mg Injection works:
Ammika 500mg injection is a bacterial growth inhibitor, acting as an antibiotic by blocking the production of vital proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Ammika 500mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Ammika 500mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptionally critical circumstances where the potential benefits outweigh the known dangers, as determined by a physician. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Ammika 500mg poses no known risk during lactation. Research in humans indicates minimal to negligible drug transfer into breast milk, posing no apparent threat to the infant.
DrivingUNSAFE
The administration of Ammika 500mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Exercise caution when administering Ammika 500mg Injection to individuals with impaired renal function. Dosage modification for Ammika 500mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Ammika 500mg Injection in patients with hepatic impairment appears to pose minimal risk. Available evidence indicates that dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Ammika 500mg Injection :
Omit a dose of Ammika 500mg Injection? Seek your physician's advice.
Facts to Know About Ammika 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Aminoglycoside antibiotics |
